001), whereas sIL-2R was significantly elevated in HCC patients when compared to those with PNALT patients and control. Depsipeptide research buy On the other hand, IL-8 was significantly lower among HCC patients when compared to the other groups (p < 0.001); but with no significance between the other groups. The scatter diagrams of the studied cytokines in the different study groups are shown in Figures 2, 3,
4 and 5. Table 2 Serum levels of sFas, sTNFR-II, sIL-2R and IL-8 in the different study groups. Cytokines (pg/ml) Control PNALT CLD HCC p -value sFas 316 ± 62.5b 605.82 ± 304ab 814.94 ± 362a 762.18 ± 437a < 0.001 sTNF-RII 375.26 ± 58.4ab 268.58 ± 129b 315.27 ± 133.5b 480.16 ± 154.4a < 0.001 sIL-2Rα 639.84 ± 78.7b 710.10 ± 422b 845.38 ± 385.2ab 1372.58 ± 779.6a 0.001 IL-8 345.84 ± 75.6a 350.7 ± 53.6a 352.33 ± 98.3a 228.61 ± 51.1b < 0.001 Values are expressed as mean ± SD. Groups with similar letters are not statistically different. A p -value < 0.05 was considered significant; PNALT: chronic hepatitis C with persistent normal alanine aminotrasferase; CLD: chronic liver disease; HCC: hepatocellular carcinoma. Figure 2 Scatter diagram representing the distribution values of sFas in the different study groups. NC: normal controls; PNALT: Chronic hepatitis C with persistent normal alanine aminotrasferase; CLD: Chronic liver disease;
HCC: hepatocellular carcinoma. Figure 3 Scatter diagram representing the distribution Afatinib values of sTNFR-II in the different study groups. NC: normal controls; PNALT: Chronic hepatitis
C with persistent normal alanine aminotrasferase; CLD: Chronic liver disease; HCC: hepatocellular carcinoma. Figure 4 Scatter diagram representing the distribution values of sIL-2Rα in the different study groups. NC: normal controls; PNALT: Chronic hepatitis C with persistent normal alanine aminotrasferase; CLD: Chronic liver disease; HCC: hepatocellular carcinoma. Figure 5 Scatter diagram representing the distribution values of IL-8 in the different study groups. NC: normal controls; PNALT: Chronic hepatitis C with persistent normal alanine aminotrasferase; CLD: Chronic liver disease; HCC: hepatocellular carcinoma. Correlation was done between the serum levels of the studied cytokines, liver enzymes and log-HCV titer. The liver Oxalosuccinic acid enzymes, aspartate aminotransaminase (AST), alanine aminotransferase (ALT), and alkaline phosphatase, were significantly correlated with sTNFR-II, sIL-2R and IL-8, as exhibited in Table 3. Table 3 Correlation of different markers, liver enzymes this website showing Pearson’s r value and p -values Labs ALT ALP log-HCV titer sFas sTNFR-II IL-2R IL-8 AST 0.55 (0.000) 0.497 (0.000) -0.481 (0.000) 0.127 (0.3) 0.265 (0.029) 0.332 (0.006) -0.415 (0.000) ALT 0.590 (0.000) 0.027 (0.828) 0.338 (0.002) 0.253 (0.021) 0.392 (0.000) -0.269 (0.014) ALP -0.218 (0.083) 0.081 (0.5) 0.342 (0.004) 0.374 (0.002) -0.488 (0.000) log-HCV titer 0.006 (0.96) -0.220 (0.067) -0.170 (0.15) 0.488 (0.000) sFas 0.276 (0.010) 0.403 (0.000) -0.